Related Experiment Video
Updated: Aug 14, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
[From basic research to clinical results. The OVERTURE, ENABLE, and RENEWAL studies]
Gustavo Pastelín Hernández1, Leonardo del Valle Mondragón, Fermín Alejandro Tenorio López
1Departamento de Formacología, Instituto Nacional de Cardiología Ignacio Chávez, INCICH, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, 14080 México, D.F. Gpastelín@aol.com
Archivos De Cardiologia De Mexico
|September 12, 2003
Summary
Angiotensin Converting Enzyme inhibitors benefit cardiac failure patients, as confirmed in the OVERTURE study. Other drug trials targeting endothelin and tumor necrosis factor were halted due to severe side effects.
Area of Science:
- Pharmacology and Molecular Design
- Cardiovascular Medicine
- Clinical Trial Analysis
Background:
- Cardiac failure remains a significant health challenge.
- Novel therapeutic strategies are crucial for improving patient outcomes.
- Understanding drug mechanisms in cardiac failure is essential.
Purpose of the Study:
- To pharmacologically analyze the results of three clinical studies (OVERTURE, ENABLE, RENEWAL) in cardiac failure patients.
- To evaluate the efficacy and safety of novel drug candidates.
- To assess the role of specific molecular targets in cardiac failure treatment.
Main Methods:
- Analysis of data from three distinct clinical trials.
- Pharmacological evaluation of Angiotensin Converting Enzyme inhibitors with dual action.
- Assessment of endothelin receptor blockade and tumor necrosis factor inhibition.
Main Results:
- The OVERTURE study confirmed the benefits of Angiotensin Converting Enzyme inhibition in cardiac failure.
- Simultaneous inhibition of neutral endopeptidase showed no significant additional benefit.
- The ENABLE and RENEWAL studies were discontinued due to major adverse events.
Conclusions:
- Angiotensin Converting Enzyme inhibitors represent a valuable therapeutic approach for cardiac failure.
- Targeting endothelin receptors or tumor necrosis factor may pose significant safety risks.
- Future cardiac failure therapies will likely involve sophisticated molecular design and targeted interventions.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...